Author

M T M Lee

Observed names: M.-T. Michael Lee, Min Ta Lee, Ming-TaMichael Lee

Observed institutions: China Medical University, Institute of Biomedical Sciences, Academia Sinica, Institute of Information Science, Academia Sinica, RIKEN, RIKEN Center for Integrative Medical Sciences, Feng Chia University, Academia Sinica

OpenAlex ID: A5073832727

Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing

2012 · M S Hershfield, J T Callaghan, et al. · Clinical Pharmacology & Therapeutics · 245

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing

2014 · K E Caudle, A E Rettie, et al. · Clinical Pharmacology & Therapeutics · 243

Genome-wide association study of bipolar I disorder in the Han Chinese population

2010 · M T M Lee, C H Chen, et al. · Molecular Psychiatry · 157

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG Interferon-α–Based Regimens

2013 · A J Muir, L Gong, et al. · Clinical Pharmacology & Therapeutics · 94

Pharmacogenomics of adverse drug reactions: implementing personalized medicine

2012 · C.-Y. Wei, M.-T. Michael Lee, et al. · Human Molecular Genetics · 87

Integrating Pharmacogenomics into the Broader Construct of Genomic Medicine: Efforts by the ClinGen Pharmacogenomics Working Group (PGxWG)

2025 · Li Gong, Clarissa J Klein, et al. · Clinical Chemistry · 19

Revalidation of CoaguChek XS Plus System for INR Monitoring in Taiwanese Patients: Effects of Clinical and Genetic Factors

2014 · Pi-Yueh Chang, Ming-Shien Wen, et al. · Biomedical Journal · 6

Re: Population-Based Case-Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk

2010 · Y.-C. Su, J.-S. Lin, et al. · JNCI Journal of the National Cancer Institute · 1

Works count: 8

Citation count: 852

H-index: 6

I10-index: 6